Paget-Schroetter Syndrome Associated with FV:Q506 and Prothrombin 20210A
- 1 August 1999
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 50 (8) , 689-692
- https://doi.org/10.1177/000331979905000811
Abstract
Effort thrombosis of the axillary-subclavian vein (Paget-Schroetter syndrome) develops usually secondary to heavy arm exertion. An underlying chronic venous compressive anomaly at the thoracic outlet or intimal damage of the axillary vein following forceful hyperabduction, external rotation of the shoulder joint has been proposed to explain the pathophysiology of this thrombosis. This condition is usually not attributed to an under lying hypercoagulability such as deficiency of natural coagulation inhibitors. Here, the authors present a case with thrombosis of the axillary-subclavian vein following an effort, with factor V Leiden and prothrombin 20210A mutations. Both factor V Leiden and the genetic variant in the prothrombin gene have been shown to confer an increased risk for venous thrombosis. Although rare, effort thrombosis may develop in a patient with hereditary thrombophilia, so laboratory evaluation should include the common causes of thrombosis.Keywords
This publication has 21 references indexed in Scilit:
- Factor V Q 506 mutation in children with thrombosisAmerican Journal of Hematology, 1996
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor VThe Lancet, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.Proceedings of the National Academy of Sciences, 1993
- Deep vein thrombosis of the axillary-subclavian veins: Epidemiologic data, effects of different types of treatment and late sequeleEuropean Journal of Vascular Surgery, 1988
- Effort-related axillosubclavian vein thrombosis: A new theory of pathogenesis and a plea for direct surgical interventionThe American Journal of Surgery, 1986
- Subclavian and axillary vein compression of musculoskeletal originBritish Journal of Surgery, 1980
- “EFFORT” THROMBOSIS OF THE AXILLARY AND SUBCLAVIAN VEINSPublished by Wolters Kluwer Health ,1971